137 related articles for article (PubMed ID: 24882046)
1. [Autosomal dominant osteopetrosis: a presentation of 3 cases and a new gene mutation].
Janer Subías E; de Arriba Muñoz A; García Iñiguez JP; Ferrer Lozano M; Sanchez Del Pozo J; Labarta Aizpun JI
An Pediatr (Barc); 2015 Jan; 82(1):e35-8. PubMed ID: 24882046
[TBL] [Abstract][Full Text] [Related]
2. Localization of a gene for autosomal dominant osteopetrosis (Albers-Schönberg disease) to chromosome 1p21.
Van Hul W; Bollerslev J; Gram J; Van Hul E; Wuyts W; Benichou O; Vanhoenacker F; Willems PJ
Am J Hum Genet; 1997 Aug; 61(2):363-9. PubMed ID: 9311741
[TBL] [Abstract][Full Text] [Related]
3. Autosomal dominant osteopetrosis revisited: lessons from recent studies.
Bollerslev J; Henriksen K; Nielsen MF; Brixen K; Van Hul W
Eur J Endocrinol; 2013 Aug; 169(2):R39-57. PubMed ID: 23744590
[TBL] [Abstract][Full Text] [Related]
4. Autosomal dominant osteopetrosis associated with renal tubular acidosis is due to a CLCN7 mutation.
Piret SE; Gorvin CM; Trinh A; Taylor J; Lise S; Taylor JC; Ebeling PR; Thakker RV
Am J Med Genet A; 2016 Nov; 170(11):2988-2992. PubMed ID: 27540713
[TBL] [Abstract][Full Text] [Related]
5. Autosomal dominant osteopetrosis: clinical severity and natural history of 94 subjects with a chloride channel 7 gene mutation.
Waguespack SG; Hui SL; Dimeglio LA; Econs MJ
J Clin Endocrinol Metab; 2007 Mar; 92(3):771-8. PubMed ID: 17164308
[TBL] [Abstract][Full Text] [Related]
6. Osteoclasts from patients with autosomal dominant osteopetrosis type I caused by a T253I mutation in low-density lipoprotein receptor-related protein 5 are normal in vitro, but have decreased resorption capacity in vivo.
Henriksen K; Gram J; Høegh-Andersen P; Jemtland R; Ueland T; Dziegiel MH; Schaller S; Bollerslev J; Karsdal MA
Am J Pathol; 2005 Nov; 167(5):1341-8. PubMed ID: 16251418
[TBL] [Abstract][Full Text] [Related]
7. Albers-Schönberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene.
Cleiren E; Bénichou O; Van Hul E; Gram J; Bollerslev J; Singer FR; Beaverson K; Aledo A; Whyte MP; Yoneyama T; deVernejoul MC; Van Hul W
Hum Mol Genet; 2001 Dec; 10(25):2861-7. PubMed ID: 11741829
[TBL] [Abstract][Full Text] [Related]
8. [Osteomyelitis of the facial skull in Albers-Schönberg osteopetrosis].
Ozmen Y; Klesper B; Lenzen J
Mund Kiefer Gesichtschir; 1997 Mar; 1(2):121-4. PubMed ID: 9410613
[TBL] [Abstract][Full Text] [Related]
9. A Case of Autosomal Dominant Osteopetrosis Type 2 with a
Kang S; Kang YK; Lee JA; Kim DH; Lim JS
J Clin Res Pediatr Endocrinol; 2019 Nov; 11(4):439-443. PubMed ID: 30759959
[TBL] [Abstract][Full Text] [Related]
10. Localization of the gene causing autosomal dominant osteopetrosis type I to chromosome 11q12-13.
Van Hul E; Gram J; Bollerslev J; Van Wesenbeeck L; Mathysen D; Andersen PE; Vanhoenacker F; Van Hul W
J Bone Miner Res; 2002 Jun; 17(6):1111-7. PubMed ID: 12054167
[TBL] [Abstract][Full Text] [Related]
11. Mapping of autosomal dominant osteopetrosis type II (Albers-Schönberg disease) to chromosome 16p13.3.
Bénichou O; Cleiren E; Gram J; Bollerslev J; de Vernejoul MC; Van Hul W
Am J Hum Genet; 2001 Sep; 69(3):647-54. PubMed ID: 11468688
[TBL] [Abstract][Full Text] [Related]
12. Chloride channel ClCN7 mutations are responsible for severe recessive, dominant, and intermediate osteopetrosis.
Frattini A; Pangrazio A; Susani L; Sobacchi C; Mirolo M; Abinun M; Andolina M; Flanagan A; Horwitz EM; Mihci E; Notarangelo LD; Ramenghi U; Teti A; Van Hove J; Vujic D; Young T; Albertini A; Orchard PJ; Vezzoni P; Villa A
J Bone Miner Res; 2003 Oct; 18(10):1740-7. PubMed ID: 14584882
[TBL] [Abstract][Full Text] [Related]
13. [Recessive osteopetrosis. Identification of a form of medium severity].
Bejaoui M; Baraket M; Lakhoua R; Mezni F; Hammou Jeddi A; Kamoun A; Kharrat H; Essoussi S; Harbi A; Ben Dridi MF
Arch Fr Pediatr; 1992; 49(7):627-31. PubMed ID: 1476480
[TBL] [Abstract][Full Text] [Related]
14. Osteopetrosis.
Stoker DJ
Semin Musculoskelet Radiol; 2002 Dec; 6(4):299-305. PubMed ID: 12541186
[TBL] [Abstract][Full Text] [Related]
15. Clcn7
Caetano-Lopes J; Lessard SG; Hann S; Espinoza K; Kang KS; Lim KE; Horan DJ; Noonan HR; Hu D; Baron R; Robling AG; Warman ML
Bone; 2017 Dec; 105():253-261. PubMed ID: 28942122
[TBL] [Abstract][Full Text] [Related]
16. Disease status in autosomal dominant osteopetrosis type 2 is determined by osteoclastic properties.
Chu K; Snyder R; Econs MJ
J Bone Miner Res; 2006 Jul; 21(7):1089-97. PubMed ID: 16813529
[TBL] [Abstract][Full Text] [Related]
17. Type II benign osteopetrosis (Albers-Schönberg disease) caused by a novel mutation in CLCN7 presenting with unusual clinical manifestations.
Letizia C; Taranta A; Migliaccio S; Caliumi C; Diacinti D; Delfini E; D'Erasmo E; Iacobini M; Roggini M; Albagha OM; Ralston SH; Teti A
Calcif Tissue Int; 2004 Jan; 74(1):42-6. PubMed ID: 14564431
[TBL] [Abstract][Full Text] [Related]
18. Elevated serum lactate dehydrogenase isoenzymes and aspartate transaminase distinguish Albers-Schönberg disease (Chloride Channel 7 Deficiency Osteopetrosis) among the sclerosing bone disorders.
Whyte MP; Kempa LG; McAlister WH; Zhang F; Mumm S; Wenkert D
J Bone Miner Res; 2010 Nov; 25(11):2515-26. PubMed ID: 20499337
[TBL] [Abstract][Full Text] [Related]
19. Identification of TCIRG1 and CLCN7 gene mutations in a patient with autosomal recessive osteopetrosis.
Yu T; Yu Y; Wang J; Yin L; Zhou Y; Ying D; Huang R; Chen H; Wu S; Shen Y; Fu Q; Chen F
Mol Med Rep; 2014 Apr; 9(4):1191-6. PubMed ID: 24535484
[TBL] [Abstract][Full Text] [Related]
20. Sclerosing bone disorders.
de Vernejoul MC
Best Pract Res Clin Rheumatol; 2008 Mar; 22(1):71-83. PubMed ID: 18328982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
